Table II.
Patient no. | Differentiation level | Regimen |
---|---|---|
1 | Well-differentiated | PEP + RT |
2 | Well-differentiated | PEP + CDDP + TS-1 + RT |
3 | Well-differentiated | TS-1 + RT |
4 | Poorly differentiated | PEP + RT |
5 | Poorly differentiated | CDDP + 5-FU |
6 | Poorly differentiated | TS-1 + RT |
7 | Poorly differentiated | PEP + RT |
8 | Poorly differentiated | CDDP + 5-FU + RT |
9 | Well-differentiated | PEP + RT |
10 | Well-differentiated | PEP + CDDP + RT |
11 | Well-differentiated | PEP + CDDP + RT |
PEP, pepleomycin; RT, radiation therapy; CDDP, cisplatin; TS-1, tegafur + gimeracil + oteracil potassium; 5-FU, 5-fluorouracil.